IGFBP4 and systemic sclerosis: Based on our findings, we propose that decreased levels of IGFBP‐4 in SSc fibroblasts may be responsible for increased CXCR4 in lung fibrosis and ultimately the promotion of CXCR4‐dependent chemotaxis of circulating monocytes and inflammatory cells, contributing to pulmonary fibrosis.